Obesity Research Today is a free monthly online journal that collates and summarizes the latest research about Obesity, including details on health, diet, prevention, exercise.

Volume 2 (2005), Issue 2 (February)

1. Using obese mouse models in research: special considerations for IACUC members, animal care technicians, and researchers.
   Lab Anim (NY), 34(2): 30-7. [Abstract] [Full-text]
2. Obesity increases the risk of incident asthma among adults.
   Eur Respir J, 25(2): 282-8. [Abstract] [Full-text]
3. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification.
   Obstet Gynecol, 105(2): 261-5. [Abstract] [Full-text]
4. Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis.
   Eur J Clin Nutr, 59(2): 155-60. [Abstract] [Full-text]
5. Obesity and renal transplant outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.
   Pediatrics, 115(2): 352-6. [Abstract] [Full-text]
6. Obese children who are referred to the pediatric endocrinologist: characteristics and outcome.
   Pediatrics, 115(2): 348-51. [Abstract] [Full-text]
7. Overweight, obesity, and health-related quality of life among adolescents: the National Longitudinal Study of Adolescent Health.
   Pediatrics, 115(2): 340-7. [Abstract] [Full-text]
8. Overweight among low-income preschool children associated with the consumption of sweet drinks: Missouri, 1999-2002.
   Pediatrics, 115(2): e223-9. [Abstract] [Full-text]
9. Body mass index and risk of malignant lymphoma in Scandinavian men and women.
   J Natl Cancer Inst, 97(3): 210-8. [Abstract] [Full-text]
10. Obesity, body fat and coronary atherosclerosis.
    Int J Cardiol, 98(2): 227-35. [Abstract] [Full-text]
11. MUNC-ing around with insulin action.
    J Clin Invest, 115(2): 219-21. [Abstract] [Full-text]
12. Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men.
    J Lipid Res, 46(2): 237-44. [Abstract] [Full-text]
13. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor.
    Am J Epidemiol, 161(4): 352-8. [Abstract] [Full-text]
14. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Clin Genet, 67(3): 230-9. [Abstract] [Full-text]
15. IKK-beta links inflammation to obesity-induced insulin resistance.
    Nat Med, 11(2): 191-8. [Abstract] [Full-text]
16. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
    Nat Med, 11(2): 199-205. [Abstract] [Full-text]
17. Perspectives on obesity and barriers to control from workers at a community center serving low-income Hispanic children and families.
    J Community Health Nurs, 22(1): 23-36. [Abstract] [Full-text]
18. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?
    Am J Cardiol, 95(4): 439-44. [Abstract] [Full-text]
19. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    J Soc Gynecol Investig, 12(2): 129-34. [Abstract] [Full-text]
20. Adipocyte insensitivity syndromes -- novel approach to nutritional metabolic problems including obesity and obesity related disorders.
    Med Hypotheses, 64(4): 826-32. [Abstract] [Full-text]
21. Preventing childhood obesity: a solution-oriented research paradigm.
    Am J Prev Med, 28(2): 194-201. [Abstract] [Full-text]
22. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
    Br J Pharmacol, 144(3): 308-16. [Abstract] [Full-text]
23. Expression of DGAT2 in white adipose tissue is regulated by central leptin action.
    J Biol Chem, 280(5): 3331-7. [Abstract] [Full-text]
24. Possible genomic imprinting of three human obesity-related genetic loci.
    Am J Hum Genet, 76(3): 427-37. [Abstract] [Full-text]
25. Renal contribution to increased clearance of exogenous growth hormone in obese hypertensive patients.
    J Clin Endocrinol Metab, 90(2): 795-9. [Abstract] [Full-text]
26. Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation.
    J Clin Endocrinol Metab, 90(2): 761-7. [Abstract] [Full-text]
27. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    J Clin Endocrinol Metab, 90(2): 1061-7. [Abstract] [Full-text]
28. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.
    J Clin Endocrinol Metab, 90(2): 741-6. [Abstract] [Full-text]
29. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects.
    J Clin Endocrinol Metab, 90(2): 1068-71. [Abstract] [Full-text]
30. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance.
    J Clin Endocrinol Metab, 90(2): 747-54. [Abstract] [Full-text]
31. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Horm Metab Res, 37(1): 49-52. [Abstract] [Full-text]
32. Effects of dietary fructose on liver steatosis in overfed mule ducks.
    Horm Metab Res, 37(1): 32-5. [Abstract] [Full-text]
33. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling.
    Growth Horm IGF Res, 15(1): 55-63. [Abstract] [Full-text]
34. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure.
    Am J Surg, 189(1): 27-32. [Abstract] [Full-text]
35. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
    Acta Psychiatr Scand, 111(3): 177-84. [Abstract] [Full-text]
36. Effects of exercise adherence on physical function among overweight older adults with knee osteoarthritis.
    Arthritis Rheum, 53(1): 24-32. [Abstract] [Full-text]
37. Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting.
    BMC Fam Pract, 6(1): 5. [Abstract] [Full-text]
38. Evaluation of adipose tissue distribution in obese fa/fa Zucker rats by in vivo MR imaging: effects of peroxisome proliferator-activated receptor agonists.
    MAGMA, 17(3): 229-35. [Abstract] [Full-text]
39. C57BL/6J and B6.V-LEPOB mice differ in the cholinergic modulation of sleep and breathing.
    J Appl Physiol, 98(3): 918-29. [Abstract] [Full-text]
40. Regulation of PPARgamma activity during adipogenesis.
    Int J Obes (Lond), 29: S13-6. [Abstract] [Full-text]
41. Atypical transcriptional regulators and cofactors of PPARgamma.
    Int J Obes (Lond), 29: S10-2. [Abstract] [Full-text]
42. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
    Arch Intern Med, 165(3): 341-5. [Abstract] [Full-text]
43. Body mass index, other cardiovascular risk factors, and hospitalization for dementia.
    Arch Intern Med, 165(3): 321-6. [Abstract] [Full-text]
44. Impact of morbid obesity on medical expenditures in adults.
    Int J Obes (Lond), 29(3): 334-9. [Abstract] [Full-text]
45. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development.
    Int J Obes (Lond), 29(3): 324-33. [Abstract] [Full-text]
46. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.
    Int J Obes (Lond), 29(3): 281-6. [Abstract] [Full-text]
47. A genome-wide scan for quantitative trait loci linked to obesity phenotypes among West Africans.
    Int J Obes (Lond), 29(3): 255-9. [Abstract] [Full-text]
48. An application of bootstrap resampling method to obtain confidence interval for percentile fatness cutoff points in childhood and adolescence overweight diagnoses.
    Int J Obes (Lond), 29(3): 340-7. [Abstract] [Full-text]
49. Coronary heart disease risk in men and the epidemic of overweight and obesity.
    Int J Obes (Lond), 29(3): 317-23. [Abstract] [Full-text]
50. Interactive effect of obesity indexes on cognition.
    Dement Geriatr Cogn Disord, 19(2): 91-6. [Abstract] [Full-text]
51. Obesity among outpatients with major depressive disorder.
    Int J Neuropsychopharmacol, 8(1): 59-63. [Abstract] [Full-text]
52. Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity.
    Bioorg Med Chem Lett, 15(5): 1467-70. [Abstract] [Full-text]
53. Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists.
    Bioorg Med Chem Lett, 15(5): 1441-6. [Abstract] [Full-text]
54. Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5.
    Proc Natl Acad Sci U S A, 102(7): 2496-501. [Abstract] [Full-text]
55. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Endocrinology, 146(3): 1473-81. [Abstract] [Full-text]
56. Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study.
    Diabetes Obes Metab, 7(2): 193-9. [Abstract] [Full-text]
57. Weight loss-associated changes in acute effects of nateglinide on insulin secretion after glucose loading: results of glucose loading on 2 consecutive days.
    Diabetes Obes Metab, 7(2): 182-8. [Abstract] [Full-text]
58. Children's perceptions of attending a residential weight-loss camp in the UK.
    Child Care Health Dev, 31(2): 223-31. [Abstract] [Full-text]
59. Overweight children in Beirut: prevalence estimates and characteristics.
    Child Care Health Dev, 31(2): 159-65. [Abstract] [Full-text]
60. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth.
    Hum Mol Genet, 14(5): 627-37. [Abstract] [Full-text]
61. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity.
    Diabet Med, 22(3): 266-72. [Abstract] [Full-text]
62. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Free Radic Biol Med, 38(6): 806-16. [Abstract] [Full-text]
63. Fluoroscopic imaging for technically difficult spinal anesthesia.
    J Clin Anesth, 17(1): 69-71. [Abstract] [Full-text]
64. Effect of acute hyperinsulinemia on ventricular repolarization in uncomplicated obesity.
    Int J Cardiol, 99(1): 161-3. [Abstract] [Full-text]
65. Quantitative analysis of the energy requirements for development of obesity.
    J Theor Biol, 234(1): 99-106. [Abstract] [Full-text]
66. Risk factors for the intermediate outcome of morbid obesity after laparoscopically placed adjustable gastric banding.
    Am J Surg, 189(2): 214-8. [Abstract] [Full-text]
67. Diet and colorectal cancer: implications for the obese and devotees of the Atkins diet.
    Colorectal Dis, 7(2): 128-32. [Abstract] [Full-text]
68. Mosaic imprinting defect in a patient with an almost typical expression of the Prader-Willi syndrome.
    Eur J Hum Genet, 13(3): 273-7. [Abstract] [Full-text]
69. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity.
    Arch Dis Child, 90(3): 258-61. [Abstract] [Full-text]
70. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation.
    Nutrition, 21(2): 269-79. [Abstract] [Full-text]
71. Effect of lean system 7 on metabolic rate and body composition.
    Nutrition, 21(2): 179-85. [Abstract] [Full-text]
72. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver.
    Nutrition, 21(2): 137-41. [Abstract] [Full-text]
73. Feasibility of measuring coronary flow velocity and reserve in the left anterior descending coronary artery by transthoracic Doppler echocardiography in a relatively obese American population.
    Echocardiography, 22(3): 225-32. [Abstract] [Full-text]
74. Effectiveness of school programs in preventing childhood obesity: a multilevel comparison.
    Am J Public Health, 95(3): 432-5. [Abstract] [Full-text]
75. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Ann Pharmacother, 39(3): 427-32. [Abstract] [Full-text]
76. Reducing sedentary behaviour and increasing physical activity among 10-year-old children: overview and process evaluation of the 'Switch-Play' intervention.
    Health Promot Int, 20(1): 7-17. [Abstract] [Full-text]
77. Healthy eating, activity and obesity prevention: a qualitative study of parent and child perceptions in Australia.
    Health Promot Int, 20(1): 19-26. [Abstract] [Full-text]
78. Behavioral features of CHARGE syndrome (Hall-Hittner syndrome) comparison with Down syndrome, Prader-Willi syndrome, and Williams syndrome.
    Am J Med Genet A, 133(3): 240-7. [Abstract] [Full-text]
79. Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance.
    Mol Endocrinol, 19(3): 794-803. [Abstract] [Full-text]
80. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome.
    Ann N Y Acad Sci, 1034: 364-74. [Abstract] [Full-text]
81. MKKS/BBS6, a divergent chaperonin-like protein linked to the obesity disorder Bardet-Biedl syndrome, is a novel centrosomal component required for cytokinesis.
    J Cell Sci, 118: 1007-20. [Abstract] [Full-text]
82. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey.
    Hypertension, 45(3): 363-7. [Abstract] [Full-text]
83. Weight loss and the renin-angiotensin-aldosterone system.
    Hypertension, 45(3): 356-62. [Abstract] [Full-text]
84. A genome scan for serum triglyceride in obese nuclear families.
    J Lipid Res, 46(3): 432-8. [Abstract] [Full-text]
85. Regulatory effect of sense line diet on cholesterol and body weight in mice fed a high-fat diet.
    Ann Nutr Metab, 48(6): 398-403. [Abstract] [Full-text]
86. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
    Metabolism, 54(3): 397-402. [Abstract] [Full-text]
87. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.
    Cancer Epidemiol Biomarkers Prev, 14(2): 459-66. [Abstract] [Full-text]
88. Leptin increases small intestinal response to cholecystokinin in leptin-deficient obese mice.
    J Surg Res, 124(1): 146-50. [Abstract] [Full-text]
89. Altered intestinal motility in leptin-deficient obese mice.
    J Surg Res, 124(1): 98-103. [Abstract] [Full-text]
90. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
    Eur J Obstet Gynecol Reprod Biol, 119(1): 87-93. [Abstract] [Full-text]
91. Exaggerated respiratory chemosensitivity and association with SaO2 level at 3568 m in obesity.
    Respir Physiol Neurobiol, 146(1): 47-54. [Abstract] [Full-text]
92. Transcriptomics applied to obesity and caloric restriction.
    Biochimie, 87(1): 117-23. [Abstract] [Full-text]
93. The role of MAPKs in adipocyte differentiation and obesity.
    Biochimie, 87(1): 51-6. [Abstract] [Full-text]
94. Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.
    Eur J Pharmacol, 509(2): 211-7. [Abstract] [Full-text]
95. Roux-en-Y gastric bypass for clinically severe obesity: normal appearance and spectrum of complications at imaging.
    Radiology, 234(3): 674-83. [Abstract] [Full-text]

© 2004-2008 Obesity Research Today. All Rights Reserved.